Summary
Multidrug-resistant (MDR) bacterial infection is a common complication of severe acute pancreatitis (SAP). This study aimed to explore the association between human leukocyte antigen-antigen D-related (HLA-DR) expression and multidrug-resistant infection in patients with SAP. A total of 24 SAP patients who were admitted to Nanjing Drum Tower Hospital between May 2015 and December 2016 were enrolled in the study. The percentages of CD4+, CD8+, natural killer (NK), and HLA-DR (CD14+) cells and the CD4+/CD8+ cell ratio on days 1,7,14, and 28 after admission were determined by flow cytometry. Eighteen patients presented with the symptoms of infection. Among them, 55.6% patients (10/18) developed MDR infection. The most common causative MDR organisms were Enterobacter cloacae and Acinetobacter baumannii. The CD4+/CD8+ cell ratio and the percentage of NK cells were similar between patients with non-MDR and patients with MDR infections. In patients without infection, the HLA-DR percentage was maintained at a high level throughout the 28 days. Compared to the patients without any infection, the HLA-DR percentage in patients with non-MDR infection was reduced on day 1 but increased and reached similar levels on day 28. In patients with MDR infection, the HLA-DR percentage remained below normal levels at all-time points. It was concluded that persistent down-regulation of HLA-DR expression is associated with MDR bacterial infection in patients with SAP.
Similar content being viewed by others
References
Beckingham IJ, Bornman PC. ABC of diseases of liver, pancreas, and biliary system. Acute pancreatitis. BMJ, 2001,322(7286):595–598
Shah AP, Mourad MM, Bramhall SR. Acute pancreatitis: current perspectives on diagnosis and management. J Inflamm Res, 2018,9(11):77–85
Working Party of the British Society of Gastroenterology; Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut, 2005,54 (Suppl 3):l-9
Bhatia M, Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol, 2000,190(2): 117–125
Koutroumpakis E, Slivka A, Furlan A, et al. Management and outcomes of acute pancreatitis patients over the last decade: A US tertiary-center experience. Pancreatology, 2017,17(l):32–40
Phillip V, Steiner JM, Algiil H. Early phase of acute pancreatitis: Assessment and management. World J Gastrointest Pathophysiol, 2014,15;5(3):158–168
HS Lee, SK Lee, DH P, et al. Emergence of multidrug resistant infection in patients with severe acute pancreatitis. Pancreatology, 2014,14(6):450–453
Liu ZM, Shen YF, Cui NQ, et al. Clinical observation of immunity for severe acute pancreatitis. Inflammation, 2011,34(5):426–431
Lukaszewicz AC, Faivre V, Payen D. Is monocyte HLA-DR expression monitoring a useful tool to predict the risk of secondary infection? Minerva Anestesiol, 2010,76(9):737–743
Lukaszewicz AC, Grienay M, Resche-Rigon M, et al. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med, 2009,37(10):2746–2752
Landelle C, Lepape A, Voirin N, et al. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med, 2010,36(11):1859–1866
Gogos C, Kotsaki A, Pelekanou A, et al. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care, 2010,14(3):R96
Wu JF, Ma J, Chen J, et al. Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis. Crit Care, 2011,15(5):R220
Lekkou A, Karakantza M, Mouzaki A, et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with communityacquired severe infections. Clin Diagn Lab Immunol, 2004,11(1):161–167
Genel F, Atlihan F, Ozsu E, et al. Monocyte HLADR expression as predictor of poor outcome in neonates with late onset neonatal sepsis. J Infect, 2010,60(3):224–228
Lin, ZQ, Guo J, Xia. Q, et al. Human leukocyte antigen-DR expression on peripheral monocytes may be an early marker for secondary infection in severe acute pancreatitis. Hepatogastroenterology, 2013,60(128):1896–1902
Kadiyala V, Suleiman SL, McNabb-Baltar J, et al. The Atlanta Classification, Revised Atlanta Classification, and Determinant-Based Classification of Acute Pancreatitis: Which Is Best at Stratifying Outcomes? Pancreas, 2016,45(4):510–515
Gravante G, Garcea G, Ong SL, et al. Prediction of mortality in acute pancreatitis: A systematic review of the published evidence. Pancreatology, 2009,9(5):601–614
Chan MC, Chiu SK, Hsueh PR, et al. Risk factors for Healthcare-Associated Extensively Drug-healthcaresssociated extensively drug-resistant Acinetobacter baumannii infections: A case-control case-control study. PLoS One, 2014,9(l):e85973
Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med, 1995,23(10): 1638–1652
Zeng YB, Zhan XB, Guo XR, et al. Risk factors for pancreatic infection in patients with severe acute pancreatitis: An analysis of 163 cases. J Dig Dis, 2014,15(7):377–385
Schwender BJ, Gordon SR, Gardner TB. Risk factors for the development of intra-abdominal fungal infections in acute pancreatitis. Pancreas, 2015,44(5):805–807
Wolk K, Docke WD, von Baehr V, et al. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood, 2000,96(1):218–223
Kylànpàâ ML, Repo H, Puolakkainen PA. Inflammation and immunosuppression in severe acute pancreatitis. World J Gastroenterol, 2010,16(23):2867–2872
Koppelman B, Neefjes JJ, de Vries JE, et al. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity, 1997,7(6):861–871
Ho YP, Sheen IS, Chiu CT, et al. A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol, 2006,101(5): 1117–1124
Cai Y, ChaiD, WangR, etal. Colistin resistae of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. Antimicrob Chemother, 2012,67(7): 1607–1615
Huang X, Li G, Yi L, et al. The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue (Chinese), 2015,27(8):667–671.
Li JL, Chen TS, Yuan CC, et al. Regulatory T cell activity in immunosuppresive mice model of Pseudomonas aeruginosa pneumonia. J Huazhong Univ Sei Technolog Med Sei, 2017,37(4):505–509
Kamiya T, Mideo N, Alizon S. Coevolution of virulence and immunosuppression in multiple infections. JEvolBiol, 2018, doi: 10.1111/jeb.l3280
Cajander S, Rasmussen G, Tina E, et al. Dynamics of monocytic HLA-DR expression differs between bacterial etiologies during the course of bloodstream infection. PLoS One, 2018,13(2):e0192883
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by the National Natural Science Fonndation of China (No. 81701953).
Rights and permissions
About this article
Cite this article
Yu, Zx., Chen, Xc., Zhang, By. et al. Association between HLA-DR Expression and Multidrug-resistant Infection in Patients with Severe Acute Pancreatitis. CURR MED SCI 38, 449–454 (2018). https://doi.org/10.1007/s11596-018-1899-9
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-018-1899-9